Skip to content
The Nexus
DossierENTITY

metastatic pancreatic cancer

Coverage of metastatic pancreatic cancer in the Nexus archive.

Earliest in view: Apr 26 · 23:00 UTCMost recent: Jun 4 · 10:30 UTC
Co-mentioned in this coverage
Revolution Medicinesorganization1daraxonrasibtopic1Food and Drug Administrationorganization1ASCO plenary sessiontopic1STAT+organization1Ben Sasseperson1Scott Pelleyperson160 Minutesorganization1Nebraskaplace1
Recent coverage
  • HEALTHJun 4 · 10:30 UTCSTAT NEWS
    STAT+: Does Revolution Medicines’ pancreatic cancer drug have even greater potential?

    Revolution Medicines' pancreatic cancer drug daraxonrasib is poised for FDA approval after showing promise in metastatic cases post-chemotherapy. The drug's potential expansion to newly diagnosed metastatic patients is under discussion following its positive reception at the ASCO plenary session.

  • POLITICSApr 26 · 23:00 UTCCBS NEWS
    Extended interview: Ben Sasse on lessons for America

    Former Nebraska Senator Ben Sasse, who has metastatic pancreatic cancer, discussed lessons for America's past and future in an extended interview with 60 Minutes' Scott Pelley. The interview was broadcast on April 26, 2026.

metastatic pancreatic cancer · Dossier · The Nexus